NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Authors :: Hall, William A.
Karrison, Theodore
McGregor, Bradley Alexander
Barata, Pedro C.
Nagar, Himanshu
Tang, Chad
Siva, Shankar
Morgan, Todd Matthew
Lang, Joshua Michael
Kamran, Sophia C.
Glide-Hurst, Carri
Sundaram, Karthik
Katz, Sharyn I.
Feng, Felix Y
McKay, Rana R.
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS4604-TPS4604, 1p
Publication Year :: 2023

Full Text Access

Tools